659 related articles for article (PubMed ID: 17014609)
21. Commercialism and medicine: an overview.
Kassirer JP
Camb Q Healthc Ethics; 2007; 16(4):377-86; discussion 439-42. PubMed ID: 18018917
[No Abstract] [Full Text] [Related]
22. Doctors and drug companies: the beauty and the beast?
Guömundsson S
Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
[No Abstract] [Full Text] [Related]
23. The challenges facing neurology, neurosurgery, and the neurosciences.
Swift TR; Ausman JI
Arch Neurol; 2005 Dec; 62(12):1814-6. PubMed ID: 16344339
[No Abstract] [Full Text] [Related]
24. Physician investment in the health care industry: a concern.
Watts C
Surg Neurol; 2009 Oct; 72(4):401-2. PubMed ID: 18786706
[No Abstract] [Full Text] [Related]
25. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
26. Industry relations.
Shortell CK
J Vasc Surg; 2011 Sep; 54(3 Suppl):1S-2S. PubMed ID: 21872106
[No Abstract] [Full Text] [Related]
27. New guidelines for the disclosure of academic-industry financial ties and modeling professionalism during medical education.
Reddi A
JAMA Pediatr; 2013 Dec; 167(12):1091-2. PubMed ID: 24081013
[No Abstract] [Full Text] [Related]
28. Academic medical centers and conflicts of interest.
Brody H
JAMA; 2006 Jun; 295(24):2848; author reply 2848-9. PubMed ID: 16804149
[No Abstract] [Full Text] [Related]
29. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
Lachin JM
Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
[TBL] [Abstract][Full Text] [Related]
30. Managing perceived conflicts of interest while ensuring the continued innovation of medical technology.
Van Haute A
J Vasc Surg; 2011 Sep; 54(3 Suppl):31S-3S. PubMed ID: 21872113
[TBL] [Abstract][Full Text] [Related]
31. The new CMSS code for interactions with companies managing relationships to minimize conflicts.
Kahn NB; Lichter AS;
J Vasc Surg; 2011 Sep; 54(3 Suppl):34S-40S. PubMed ID: 21872114
[TBL] [Abstract][Full Text] [Related]
32. Clinical trials. Proposed rules aim to curb financial conflicts of interest.
Kaiser J
Science; 2002 Jan; 295(5553):246-7. PubMed ID: 11786611
[No Abstract] [Full Text] [Related]
33. Industry and the profession of medicine: balancing appropriate relationships with the need for innovation.
Lewin J; Arend TE
J Vasc Surg; 2011 Sep; 54(3 Suppl):47S-9S. PubMed ID: 21872116
[TBL] [Abstract][Full Text] [Related]
34. The private practicing physician-investigator: ethical implications of clinical research in the office setting.
Klein JE; Fleischman AR
Hastings Cent Rep; 2002; 32(4):22-6. PubMed ID: 12362520
[TBL] [Abstract][Full Text] [Related]
35. A perspective on commercial relationships between ophthalmology and industry.
Jampol LM; Packer S; Mills RP; Day SH; Lichter PR;
Arch Ophthalmol; 2009 Sep; 127(9):1194-202. PubMed ID: 19752430
[TBL] [Abstract][Full Text] [Related]
36. American Society of Clinical Oncology policy for relationships with companies: background and rationale.
American Society of Clinical Oncology
J Clin Oncol; 2013 Jun; 31(16):2037-42. PubMed ID: 23610121
[TBL] [Abstract][Full Text] [Related]
37. Conflict of interest with industry and the challenges for surgical education.
Schwarze ML
J Am Coll Surg; 2009 Dec; 209(6):766-8. PubMed ID: 19959047
[No Abstract] [Full Text] [Related]
38. An American-Canadian neurologist returns to Canada.
Ross IB
Can J Neurol Sci; 2005 May; 32(2):265-6; author reply 266. PubMed ID: 16018170
[No Abstract] [Full Text] [Related]
39. Industry working with physicians through professional medical associations.
Dalsing MC
J Vasc Surg; 2011 Sep; 54(3 Suppl):41S-6S. PubMed ID: 21872115
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceuticals and medical devices: business practices. Issue brief.
Thomson Reuters/West
Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
